TRI 0.00% 2.5¢ trivarx ltd

Ann: FDA Strategy and Regulatory Update, page-251

  1. 4 Posts.
    Also agree with your sentiments john12, however the short / med term value in this stock is clearly FDA approval (which I think is likely) and not commercialisation of ilumen. In the longer term (say 12-24m) post FDA there will be some upside to revenue growth but SP is all about FDA!!
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
0.000(0.00%)
Mkt cap ! $10.24M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $52.75K 2.106M

Buyers (Bids)

No. Vol. Price($)
2 733562 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 55738 1
View Market Depth
Last trade - 13.26pm 21/06/2024 (20 minute delay) ?
TRI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.